Minnesota medtech accelerator debuts, with Medtronic vet at the helm

An executive with R&D experience from Medtronic ($MDT) is co-launching Inceptis, a new medtech accelerator based in Minnesota. Daniel Sigg served as senior research manager at Medtronic a few years back and has also served in executive roles at various life sciences companies, according to his LinkedIn profile. Devicix, a product development and engineering firm, is also an equal partner in the enterprise, MedCity News reports. Inceptis will focus on Class II medical devices and plans to begin raising between $10 million and $14 million in the fall, according to the article. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.